Resource Center

This section contains international research and may reference indications not approved in all regions. Please consult local approved indications before use.

Filter By:

Search
resources-top-bg
  • Publications

Hybrid remote and in-clinic maternal-fetal surveillance for women with gestational diabetes: A prospective pilot study

Hybrid remote and in-clinic maternal-fetal surveillance for women with gestational diabetes: A prospective pilot study
Remote visits had a success rate of 97.4% (38 of 39), with significantly shorter durations compared with in-clinic visits (median 59.0 min vs. 159.0 min, P < 0.001). Women expressed
Read more
  • Publications

The effect of home ultrasound on maternal anxiety in patients with previous recurrent pregnancy loss: A randomized control trial

Integrating routine home-ultrasound telemedicine visits into prenatal care can significantly reduce maternal anxiety during pregnancy and contribute to greater maternal attachment in individuals with a history of recurrent pregnancy loss.
Read more
  • Ongoing research

Empowering High-Risk Pregnant Women: A New Hybrid Model for Hospital at Home

Empowering High-Risk Pregnant Women: A New Hybrid Model for Hospital at Home
HaH for High-Risk Pregnant women offers a promising alternative to prolonged hospital admissions, empowering women while maintaining quality of care. Further research is needed to explore the scalability and management
Read more
  • Ongoing research

Self-Operated Home Ultrasound and Remote Experts Review – Real-life Data Results

Self-Operated Home Ultrasound and Remote Experts Review - Reallife Data Results
Retrospective review of all self performed scans between 4/2020 to 3/2022. Ultrasound scanning and interpretation variables were analyzed, including scan adequacy, types of results and recommendations provided following scan review.
Read more
  • Publications

Integrating technologies to provide comprehensive remote fetal surveillance: A prospective pilot study

Integrating technologies to provide comprehensive remote fetal surveillance: A prospective pilot study
Remote fetal well-being assessment is feasible and time-saving and results in high patient satisfaction. This novel paradigm of comprehensive remote maternal and fetal assessment is associated with important clinical, socioeconomic,
Read more
  • Publications

Review article: Empowering women’s health: Transformative advances in telemedicine

Empowering Women’s Health: Transformative Advances in Telemedicine

Abstract: In light of the COVID-19 pandemic and other emergencies, telehealth has become vital for improving women’s health since it offers easy accessto medical care. This strategy makes virtual consultations,

Read more
resources-bottom-bg

the news pulse

We invite you to keep up to date with the latest updates by registering to our quarterly newsletter

Subscribe
news-pulse-doctor
news-pulse-lady1
news-pulse-couple
news-pulse-lady2
about-collaborations-bottom-bg

FAQ

Frequently asked question

To begin working with Pulsenmore, clinicians or healthcare organizations can submit a request through the contact form and indicate their interest in a collaboration. Our team will follow up to introduce the system, review clinical and operational needs, and confirm alignment with your care model.

Once aligned, a service agreement is established. From that point, eligible patients can obtain the device through authorized channels and receive remote monitoring services as part of the clinician’s care offering.

No. Pulsenmore does not replace diagnostic or scheduled in-clinic ultrasound examinations.

Pulsenmore supports secure access to scan data, which can be referenced or documented in the EMR in accordance with institutional policies.

Pulsenmore is used as an adjunct within physician-defined care pathways. Use is determined by patient risk profile and clinical judgment and does not replace standard prenatal imaging schedules.

Pulsenmore collects four types of data:

• Service logs: Application usage logs, such as performance logs and errors.

• Technical information about the smartphone: Smartphone capabilities, application version, language, etc.

• Clinical information: Ultrasound clips scan time (see Privacy Statement)

• Interpreter Data: The identifiers of the clinicians that interpret the scans.me, scan measurements and last menstrual period (LMP).

The Pulsenmore was designed to follow ALARA (As Low As Reasonably Achievable) principles as follows:

The system supports only low frequency (2-5MHz), the duration of the scan is limited up to 3 minutes in the App guided mode, or at the clinician’s discretion in the clinician guided mode, only clinician can modify the ultrasound parameters (i.e., depth, gain, frequency etc.), each scan is enabled only upon the approval of a medical professional. The system was authorized by FDA through the de novo classification process.

Explore More

Pulsenmore is provided through participating healthcare providers. Ask your doctor if Pulsenmore is part of their prenatal care offering. If they work with us, they can prescribe the device, allowing you to purchase it and start using the service as part of your pregnancy care.

Pulsenmore is designed for use from week 14 of pregnancy and for single-fetus pregnancies. To ensure accurate monitoring and continuous clinical feedback, each device is personal and intended to be used only by you throughout your current pregnancy, keeping you securely connected to your care team.

Because it gives you peace of mind when you need it most. Pulsenmore lets you check on your baby from the comfort of your home, while staying connected to real medical care. It’s the only at-home ultrasound solution where every scan is reviewed by qualified medical professionals, so you get trusted clinical insight, not uncertainty.

Yes. Pulsenmore is based on the same ultrasound technology used routinely in clinics. Scans are performed within established safety guidelines and reviewed by a medical professional, so you receive reliable clinical insight while maintaining the safety of both you and your baby.

Every scan requires medical interpretation, and its important to wait until the files are fully uploaded. You are not expected to understand or interpret the ultrasound scans; follow the app’s instructions to scan, and receive a response from skilled ultrasound professionals .

Yes, the device is reliable and was tested, validated and approved for use in the US, Europe, Australia, Brazil, Switzerland, the UK, Colombia and Israel. Over 200,000 successful scans have been performed since the launch of the technology. These numbers demonstrate that women can confidently scan themselves, as the diagnoisis it self is being done by a trained clinical team. The remote clinical team can accurately identify parameters related to fetal vitality, such as fetal heartbeat, fetal movements, and amniotic fluid volume, based on these scans.

Explore More